JOHNSON KENNETH ERLAND
Insider CIK 1743774 · XERS See Remarks · XERS See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2025-01-31 | 2025-02-03 | 15,476 | $3.56 | $55.1K | 346,288 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2025-01-31 | 2025-02-03 | 25,842 | $3.56 | $92.0K | 320,446 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2025-01-03 | 2025-01-07 | 12,401 | $3.61 | $44.8K | 361,764 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2024-01-31 | 2024-08-09 | 15,131 | $2.46 | $37.2K | 373,036 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2024-01-31 | 2024-01-31 | 175,000 | — | $0 | 446,860 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2024-01-29 | 2024-08-09 | 10,747 | $2.66 | $28.6K | 388,167 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2024-01-03 | 2024-08-09 | 12,400 | $2.24 | $27.8K | 398,914 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2023-01-31 | 2024-08-09 | 3,393 | $1.24 | $4.2K | 411,314 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2023-01-31 | 2023-02-01 | 100,000 | — | $0 | 269,783 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2023-01-29 | 2024-08-09 | 11,029 | $1.26 | $13.9K | 414,707 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2023-01-03 | 2024-08-09 | 12,400 | $1.12 | $13.9K | 425,736 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2022-01-31 | 2024-08-09 | 2,307 | $2.11 | $4.9K | 438,136 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2022-01-29 | 2024-08-09 | 7,497 | $2.11 | $15.8K | 440,443 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2022-01-03 | 2022-01-05 | 75,000 | — | $0 | 165,865 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 100,000 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 33,686 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 5,280 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 39,633 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 21,401 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 32,500 | — | $0 | 0 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 39,633 | — | $0 | 39,633 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 32,500 | — | $0 | 32,500 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 21,401 | — | $0 | 21,401 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 5,280 | — | $0 | 5,280 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 33,686 | — | $0 | 33,686 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer | 2021-10-05 | 2021-10-05 | 11,250 | — | $0 | 78,333 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer | 2021-10-05 | 2021-10-05 | 78,333 | — | $0 | 0 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2021-10-05 | 2021-10-05 | 78,333 | — | $0 | 89,583 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2021-10-05 | 2021-10-05 | 11,250 | — | $0 | 11,250 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award | 2021-01-29 | 2021-02-01 | 65,000 | — | $0 | 91,890 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award deriv | 2020-08-14 | 2020-08-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award | 2020-06-30 | 2020-07-15 | 775 | $2.26 | $1.8K | 26,890 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | P Buy | 2020-02-14 | 2020-02-18 | 2,410 | $4.15 | $10.0K | 6,115 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award | 2020-01-31 | 2020-03-02 | 20,000 | — | $0 | 26,115 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award | 2019-12-31 | 2020-01-06 | 286 | $5.99 | $1.7K | 3,705 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award | 2019-07-01 | 2019-07-03 | 174 | $9.72 | $1.7K | 3,419 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | P Buy | 2019-02-19 | 2019-02-25 | 1,000 | $10.00 | $10.0K | 3,245 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award deriv | 2019-01-31 | 2019-02-01 | 32,500 | — | $0 | 32,500 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | C Conversion deriv | 2018-06-25 | 2018-06-27 | 4,000 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | C Conversion | 2018-06-25 | 2018-06-27 | 2,245 | — | $0 | 2,245 | SEC↗ |